Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC

PACIFIC Investigators

Research output: Contribution to journalArticlepeer-review

1306 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC'. Together they form a unique fingerprint.

Medicine & Life Sciences